Wellington Management Group LLP Has $1.94 Billion Stake in HCA Healthcare, Inc. (NYSE:HCA)

Wellington Management Group LLP reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 8.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,462,339 shares of the company’s stock after selling 591,060 shares during the period. Wellington Management Group LLP owned about 2.62% of HCA Healthcare worth $1,939,671,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare during the fourth quarter worth $31,000. Tidemark LLC bought a new stake in shares of HCA Healthcare in the 4th quarter valued at about $36,000. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare in the third quarter worth approximately $39,000. Activest Wealth Management increased its position in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. boosted its stake in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after purchasing an additional 50 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Bank of America cut their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 27th. Truist Financial lowered their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. Royal Bank of Canada cut their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. Finally, KeyCorp cut their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Stock Performance

NYSE HCA opened at $342.25 on Monday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The firm has a market cap of $84.26 billion, a price-to-earnings ratio of 15.58, a PEG ratio of 1.10 and a beta of 1.68. The company has a fifty day moving average price of $324.53 and a 200-day moving average price of $340.92. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the firm posted $5.90 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.84%. HCA Healthcare’s payout ratio is currently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.